Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07236034 · ClinicalTrials.gov registry record · NA
ARISe at UMass Chan
A NA study of Vaccination and Vaccination Promotion, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 1
- Study location
NCT07236034: Recruiting NA study of Vaccination and Vaccination Promotion, sponsored by University of Massachusetts, Worcester.
NCT07236034 is a NA study of Vaccination and Vaccination Promotion that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 700 participants, below the 10,175-participant average among 12 other Vaccination trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07236034, a NA study of Vaccination and Vaccination Promotion, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to identify the most impactful strategies for capturing attention and enhancing effectiveness of vaccine promotion messages. This will be done using an online survey that employs remote eye-tracking and self report measures to evaluate response to sample vaccine promotion social media content in rural populations in New England. Participants will be randomly assigned into one of 14 conditions in a 2(source: expert vs. influencer) by 7 (themes: constructs from 7C Vaccine Framework) experiment and view sample messages and then answer questions about their attitudes and beliefs while being monitored for eye-tracking.
Primary Outcome
Participants' perception of the credibility of the message source will be assessed using a 7-point Likert scale measured across four items. Participants will be asked to rate the following four items on this scale: To what extent do you believe the source of the message to be… (1=not at all, 7=very much so) 1. Fair 2. Accurate 3. Telling the whole story 4. Trustworthy Unit of measure: Scale score 1-7, mean
Conditions Studied
Interventions
- BEHAVIORAL Exposure to source and message content
Study Locations (1)
Massachusetts
- University of Massachusetts Chan Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT07236034 shows while recruiting
NCT07236034 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 10,175-participant average among 12 other Vaccination trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Exposure to source and message content is the first listed.
NCT07236034 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07236034 about?
NCT07236034 is a clinical study titled "ARISe at UMass Chan". The goal is to identify the most impactful strategies for capturing attention and enhancing effectiveness of vaccine promotion messages. This will be done using an online survey that employs remote eye-tracking and self report measures to evaluate response to sample vaccine promotion social media co...
What is the current status of trial NCT07236034?
This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2025-12-01. Estimated completion is 2026-09-30.
What conditions does trial NCT07236034 study?
This clinical trial studies the following conditions: Vaccination, Vaccination Promotion.
What interventions are being tested in trial NCT07236034?
The interventions under investigation include: Exposure to source and message content (BEHAVIORAL).
Who is sponsoring clinical trial NCT07236034?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07236034 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07236034's enrollment target sits among peer trials
700 8th of 12 higher than 5 of 12 other Vaccination trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaccination trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
RECRUITING · NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
RECRUITING · NA
-
Kaiser Colorado Flu Nudge
ACTIVE NOT RECRUITING · NA
-
Text Message Reminder-Recalls For Early Childhood Vaccination
COMPLETED · NA
-
The STOP-HPV Trial 2: Performance Feedback Intervention
COMPLETED · NA
-
P3+ Intervention Phase
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI